Last price paid | 1.25 | |
Change | +3.31% [ +0.04 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 17.05.2024 17:20 |
Fixing | n.a. |
Settlement date | 15.05.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +39.44% |
Year to date (YTD) | +123.21% |
1 month | +89.39% |
3 months | +60.26% |
1 year | +58.23% |
3 years | n.a. |
Issue price | 0.90 |
Underlying price on issue | 92.57 |
Premium | 0.07% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1250733065 |
Symbol | INOAIZ |
Security | 125073306 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Novartis N, CH0012005267 |
Underlying ISIN | CH0012005267 |
Funding level | 81.074900 |
Stop-loss level | 83.359300 |
Distance to stop-loss level | 10.58% |
Long/Short type | Long |
Subscription ratio | 15.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 11.05.2023 |
Premium | 7.17% |
Premium p.a. | n.a. |
Leverage | 4.95 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 12.145100 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Compagnie Financi... | 144.75 |
Swiss Re | 110.10 |
Givaudan | 4'180.00 |
Nestlé SA | 96.62 |
LOGITECH INT. | 82.40 |
Name | Price |
---|---|
SONOVA HLDG N | 291.20 |
Partners Group Ho... | 1'258.00 |
KUEHNE & NAGEL | 247.80 |
Alcon AG | 80.08 |
GEBERIT N | 561.40 |